Company intelligence / Profile preview

Point72 Ventures

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Point72 Ventures is an active global venture capital firm affiliated with Point72 and backed by Steven A. Cohen. The firm invests from seed through pre-IPO across thematic sectors including artificial intelligence, consumer, defense tech, and healthcare. In healthcare, Point72 Ventures focuses on early-stage founders using technology and computation to improve healthcare delivery and infrastructure rather than developing a traditional drug pipeline. Its disclosed healthcare-related portfolio includes companies such as Adonis, Heidi Health, CueZen, Stellar Health, and Bliss Aesthetics. The organization operates as an investor, not as a drug developer, manufacturer, CRO, or commercial-stage biopharma company.

Industry: Investors

Beyond the preview

Go deeper on Point72 Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Point72 Ventures.

Explore the full profile